首页 > 市场调查报告书 > 医疗设备

生技设备

微流体市场规模、份额和成长分析（按产品、材料、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900198

微流体市场规模、份额和成长分析（按产品、材料、应用、最终用户和地区划分）－2026-2033年产业预测

Microfluidics Market Size, Share, and Growth Analysis, By Product (Microfluidics-based Device, Microfluidic Components), By Material (Glass, Silicon), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球微流体市场规模将达到 244.8 亿美元，到 2025 年将达到 276.1 亿美元，到 2033 年将达到 723.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.8%。

微流体装置利用液体和气体在微观尺度上的独特物理和化学性质，相较于传统系统具有显着优势。这些装置透过减少所需的样品、试剂和化学品用量，降低了应用的整体成本。其广泛的应用领域，包括毛细管电泳、免疫检测和流式细胞技术，已成为疾病筛检和癌症早期检测等过程中不可或缺的工具。慢性病和感染疾病的上升以及人口老化推动了市场成长。此外，製造商和开发商对微流体技术进步的日益关注也促进了行业的扩张。为拓展新市场和提升生产能力所做的共同努力，也推动了微流体解决方案的持续发展和市场需求。

全球微流体市场驱动因素

全球微流体市场的成长主要受到微流体技术创新进步的显着影响，例如晶片实验室和晶片器官系统。这些先进技术不仅能够实现快速、精准的诊断流程，还能促进药物递送系统的改进，这对个人化医疗、即时检测和药物研发至关重要。因此，在医疗保健应用领域对高效能、精准解决方案需求不断增长的推动下，市场持续扩张。这种发展趋势标誌着诊断和治疗方法的开发与交付方式发生了变革性转变，也是推动整个市场向前发展的动力。

全球微流体市场限制因素

微流体市场面临的主要挑战之一是新兴经济体对此技术的认知度和应用率不足。这些地区的医疗服务提供者往往对微流体技术的优点和应用了解有限，导致其应用缓慢，对创新诊断和治疗解决方案的需求不足。这种知识鸿沟阻碍了微流体技术的进步和发展，使其在这些市场的潜在优势无法充分发挥。因此，对医疗专业人员进行微流体技术价值的教育和培训至关重要，这有助于提高技术的接受度，并刺激该技术能够产生重大影响的地区的市场成长。

全球微流体市场趋势

全球微流体市场正呈现出显着的发展趋势，这主要得益于对照护现场（POC）解决方案日益增长的需求，这些解决方案优先考虑快速、准确的诊断。这种转变正在革新传统的医疗服务模式，使患者能够更及时地获得医疗服务，尤其是在医疗资源匮乏的农村地区。随着医疗服务提供者寻求透过简化检测流程来改善治疗效果，微流体设备在急诊和居家照护中的应用也日益广泛。对个人化医疗的关注以及人们对即时检测优势的日益重视，进一步加速了微流体技术在各领域的应用。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific（US）
Becton, Dickinson, and Company（US）
Agilent Technologies（US）
Bio-Rad Laboratories（US）
F. Hoffmann-La Roche（Switzerland）
Danaher Corporation（US）
Illumina Inc.（US）
Fluidigm Corporation（US）
Abbott Laboratories（US）
BioMerieux（France）
Hologic（US）
Quidel Corporation（US）
SMC Corporation（Japan）
Parker-Hannifin Corporation（US）
IDEX Corporation（US）
Fortive Corporation（US）
Aignep SpA（Italy）
Dolomite Microfluidics（UK）
Elveflow（France）
uFluidix（Canada）
NanoString Technologies（US）
Nortis Inc.（US）
Innovative Biochips, LLC（US）
Fluidic Analytics（UK）

结论与建议

简介目录

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 24.48 Billion in 2024 and is poised to grow from USD 27.61 Billion in 2025 to USD 72.38 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

Microfluidic devices leverage the unique physical and chemical properties of liquids and gases at the microscale, offering significant advantages over traditional systems. These devices reduce overall application costs by requiring smaller volumes of samples, reagents, and chemicals. Their broad applications extend to capillary electrophoresis, immunoassays, flow cytometry, and more, making them vital for processes such as disease screening and early cancer detection. The market is experiencing growth fueled by rising chronic and infectious disease prevalence, coupled with an aging population. Moreover, increasing interest from manufacturers and developers in advancing microfluidic technology is driving industry expansion. Collaborative efforts to penetrate new markets and enhance production capabilities also contribute to the ongoing evolution and demand for microfluidic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segments Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Microfluidics Market

The growth of the global microfluidics market is significantly influenced by innovative advancements in microfluidic technologies, such as lab-on-a-chip and organ-on-chip systems. These sophisticated technologies facilitate rapid and precise diagnostic processes, along with improved drug delivery systems, which are crucial for personalized medicine, point-of-care testing, and pharmaceutical research. As a result, the market continues to expand, driven by the increasing demand for efficient and accurate solutions in healthcare and medical applications. This evolution represents a transformative shift in how diagnostics and therapeutics are developed and administered, thereby propelling the overall market forward.

Restraints in the Global Microfluidics Market

One of the significant challenges facing the microfluidics market is the lack of awareness and adoption in emerging economies. Healthcare providers in these regions often have limited understanding of the advantages and applications of microfluidic technologies, resulting in slow integration and insufficient demand for innovative diagnostic and treatment solutions. This knowledge gap hinders the progress and growth of microfluidics, as potential benefits remain untapped in these markets. Consequently, efforts to educate and inform healthcare professionals about the value of microfluidics are crucial for fostering acceptance and stimulating market growth in areas where such technologies could have a substantial impact.

Market Trends of the Global Microfluidics Market

The Global Microfluidics market is witnessing a significant trend driven by the increasing demand for point-of-care (POC) testing solutions, which prioritize rapid and accurate diagnostics. This shift enhances patient access to timely care, particularly in underserved and rural areas, thereby revolutionizing traditional healthcare delivery models. The integration of microfluidic devices in both emergency settings and home care is on the rise, as healthcare providers seek to improve outcomes through streamlined testing processes. The focus on personalized medicine and the growing awareness of the advantages of POC diagnostics are further accelerating the adoption of microfluidics technologies across various sectors.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case studies
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Macro-Economic Indicators
PESTEL Analysis
Top Investment Analysis
Key Success Factor
Degree of Competition

Microfluidics Market by Product & CAGR (2026-2033)

Market Overview
Microfluidics-based Device
Microfluidic Components
- Microfluidic Chip
- Flow And Pressure Sensors
- Flow And Pressure Controllers
- Micropumps
- Microfluidic Valves
- Microneedles
- Other Components

Microfluidics Market by Material & CAGR (2026-2033)

Market Overview
Glass
Silicon
Polymer
Others

Microfluidics Market by Application & CAGR (2026-2033)

Market Overview
In Vitro Diagnostics
- Clinical Diagnostics
- Point of Care Testing
- Veterinary Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
- Lab Analytics
- Proteomic analysis
- Genomic analysis
- Cell-based assays
- Capillary electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

Microfluidics Market by End-user & CAGR (2026-2033)

Market Overview
Hospital and Diagnostic Centers
Academic and Research Institute
Pharmaceutical & Biotechnology Companies

Microfluidics Market Size & CAGR (2026-2033)

Market Overview
North America (Product, Material, Application, End User)
- US
- Canada
Europe (Product, Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, Application, End User)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parker-Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEX Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortive Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aignep S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nortis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Biochips, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidic Analytics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments